Agribusiness

 

Consumer Goods

 

Heavy Industry

 

Hi-Tech & Media

 

Life Sciences

 

Services

Pathology Analysis & Statistics, June 2013

You might be interested in: cancer, breast cancer, prostate cancer, more »

» Purchase Premium Reports

1-30 of about 1 600 reports
OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017

  • $ 5 995
  • Industry report
  • April 2013
  • by Global Data

OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017 Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, ...

  • Industries : Pathology
  • Countries : United States
PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • April 2013
  • by Global Data

PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Chronic Myeloid Leukemia (CML) ...

  • Industries : Pathology
  • Countries : United States
PharmaPoint: Chronic Myeloid Leukemia (CML) - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • April 2013
  • by Global Data

PharmaPoint: Chronic Myeloid Leukemia (CML) - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Chronic Myeloid Leukemia (CML) - France ...

  • Industries : Pathology
  • Countries : France
PharmaPoint: Chronic Myeloid Leukemia (CML) - Germany Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - Germany Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • April 2013
  • by Global Data

PharmaPoint: Chronic Myeloid Leukemia (CML) - Germany Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Chronic Myeloid Leukemia (CML) - ...

  • Industries : Pathology
  • Countries : Germany
PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • April 2013
  • by Global Data

PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Chronic Myeloid Leukemia (CML) ...

  • Industries : Pathology
  • Countries : United Kingdom
PharmaPoint: Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • April 2013
  • by Global Data

PharmaPoint: Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Chronic Myeloid Leukemia (CML) - Japan ...

  • Industries : Pathology
  • Countries : Japan
PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • April 2013
  • by Global Data

PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy ...

  • Industries : Pathology
  • Countries : Italy
PharmaPoint: Chronic Myeloid Leukemia (CML) - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • April 2013
  • by Global Data

PharmaPoint: Chronic Myeloid Leukemia (CML) - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Chronic Myeloid Leukemia (CML) - Spain ...

  • Industries : Pathology
  • Countries : Spain
PharmaPoint: Multiple Sclerosis - UK Drug Forecast and Market Analysis to 2022

PharmaPoint: Multiple Sclerosis - UK Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2013
  • by Global Data

PharmaPoint: Multiple Sclerosis - UK Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - UK Drug Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : United Kingdom
PharmaPoint: Multiple Sclerosis - Germany Drug Forecast and Market Analysis to 2022

PharmaPoint: Multiple Sclerosis - Germany Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2013
  • by Global Data

PharmaPoint: Multiple Sclerosis - Germany Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - Germany Drug Forecast and ...

  • Industries : Pathology
  • Countries : Germany
PharmaPoint: Multiple Sclerosis - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Multiple Sclerosis - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2013
  • by Global Data

PharmaPoint: Multiple Sclerosis - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - France Drug Forecast and ...

  • Industries : Pathology
  • Countries : France
PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2013
  • by Global Data

PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market ...

  • Industries : Pathology
  • Countries : United States
PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2022

PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2013
  • by Global Data

PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market ...

  • Industries : Pathology
  • Countries : India
PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022

PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2013
  • by Global Data

PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market ...

  • Industries : Pathology
  • Countries : China
PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2022

PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2013
  • by Global Data

PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and ...

  • Industries : Pathology
  • Countries : Canada
PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2013
  • by Global Data

PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market ...

  • Industries : Pathology
  • Countries : Spain
PharmaPoint: Multiple Sclerosis - Italy Drug Forecast and Market Analysis to 2022

PharmaPoint: Multiple Sclerosis - Italy Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2013
  • by Global Data

PharmaPoint: Multiple Sclerosis - Italy Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - Italy Drug Forecast and Market ...

  • Industries : Pathology
  • Countries : Italy
PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022

PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2013
  • by Global Data

PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - United Kingdom Drug ...

  • Industries : Pathology
  • Countries : United Kingdom
PharmaPoint: Multiple Sclerosis - Japan Drug Forecast and Market Analysis to 2022

PharmaPoint: Multiple Sclerosis - Japan Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • March 2013
  • by Global Data

PharmaPoint: Multiple Sclerosis - Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - Japan Drug Forecast and Market ...

  • Industries : Pathology
  • Countries : Japan
EpiCast Report: Asthma - Epidemiology Forecast to 2022

EpiCast Report: Asthma - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • May 2013
  • by Global Data

EpiCast Report: Asthma - Epidemiology Forecast to 2022 Summary Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004 ...

  • Industries : Pathology
EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022

EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • May 2013
  • by Global Data

EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022 Summary Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an ...

  • Industries : Pathology
  • Countries : World, Australia, Brazil, Spain, United States, United Kingdom, Italy, France, Germany
MediFocus: Medical Devices for the Treatment of Obesity

MediFocus: Medical Devices for the Treatment of Obesity

  • $ 3 995
  • Industry report
  • May 2013
  • by Global Data

MediFocus: Medical Devices for the Treatment of Obesity Summary The obesity treatment market is drastically underserved and considerably underdeveloped. While bariatric surgery has significant improvement ...

  • Industries : Pathology
EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022

EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • April 2013
  • by Global Data

EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022 Summary Chronic Myeloid Leukemia (CML) is a rare cancer of the white blood cells characterized by increased and unregulated growth ...

  • Industries : Pathology
  • Countries : United States, Japan, World, Spain, Italy, France, Germany
EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022

EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • March 2013
  • by Global Data

EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022 Summary Cystic fibrosis (CF) is the most common inherited rare disease in North America and Europe, with more than 27,000 cases in the ...

  • Industries : Pathology
  • Countries : United States, France, Europe, United Kingdom, World, Spain, Italy, Germany
EpiCast Report: Hepatitis C Virus - Epidemiology Forecast to 2022

EpiCast Report: Hepatitis C Virus - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • March 2013
  • by Global Data

EpiCast Report: Hepatitis C Virus - Epidemiology Forecast to 2022 Summary Hepatitis C is a largely asymptomatic liver disease caused by the hepatitis C virus (HCV). HCV is an escalating public health ...

  • Industries : Pathology
EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2022

EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • March 2013
  • by Global Data

EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2022 Summary Lung cancer is a disease of uncontrolled cell growth in the lung tissues. It is one of the most commonly occurring ...

  • Industries : Pathology
  • Countries : World
EpiCast Report: Dry Eye Syndrome - Epidemiology Forecast to 2022

EpiCast Report: Dry Eye Syndrome - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • March 2013
  • by Global Data

EpiCast Report: Dry Eye Syndrome - Epidemiology Forecast to 2022 Summary Dry eye syndrome, also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye caused by dryness, decreased ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany, Japan, India, China
EpiCast Report: Psoriasis - Epidemiology Forecast to 2022

EpiCast Report: Psoriasis - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • March 2013
  • by Global Data

EpiCast Report: Psoriasis - Epidemiology Forecast to 2022 Summary Psoriasis is an immune-mediated chronic disorder of the skin characterized by redness and irritation. It affects people of both sexes ...

  • Industries : Pathology
  • Countries : India, Japan, China, World, United States, Asia, Europe, Spain, Italy, France, Germany
EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast to 2022

EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • March 2013
  • by Global Data

EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast to 2022 Summary Dermatophytic onychomycosis (DO) is an infection of the nail fold or nail plate with dermatophytes, a type of fungus, ...

  • Industries : Pathology
  • Countries : Japan
Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022

Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • May 2013
  • by Global Data

Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Gleevec (Chronic Myeloid Leukemia) - Forecast and ...

  • Industries : Pathology
  • Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom

» Download Public Reports

About 12 000 reports
Netherlands: Country Overview, 2013, focus on Pathology

Netherlands: Country Overview, 2013, focus on Pathology

  • Country report
  • June 2013
  • 25 pages

Company Report: Pathology In Japan For Year 2013

May 2013

Company Report: Pathology In China For Year 2013

June 2013

Company Report: Brain Cancer In The United States For Year 2013

June 2013

World Pharmaceutical Business Overview

June 2013

U.s. Cancer Industry

May 2013

The Canadian Pharmaceutical Industry : Innovation And Technology ...

June 2013

U.s. Pharmaceutical Industry Analysis

June 2013

Global Chronic Pain Market Overview (chronic Pain, Breast Cancer)

June 2013

The Indian Pharmaceutical Industry Analysis

June 2013
More Reports to Download »

» Read our Company Profiles

28 Companies

GlaxoSmithKline P.L.C.

United States

Eli Lilly and Co.

United States

Pfizer Inc.

United States

AstraZeneca PLC

United Kingdom

Abbott Laboratories

United States
More Companies »

Privacy Policy by TRUSTe

Reportlinker.com © Copyright 2013. All rights reserved.

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.